Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)
Clinical trial NCT02414139 · COMPLETED
Trial details
- NCT number
- NCT02414139
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-11
- Primary completion
- 2023-04-12
- Enrollment
- 373
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.